Can HIV incidence testing be used for evaluating HIV intervention programs? A reanalysis of the Orange Farm male circumcision trial (ANRS-1265)

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Fiamma, Agnès ^a   Lissouba, Pascale ^b   Amy, Oliver E ^c,d   Singh, Beverley ^e   Laeyendecker, Oliver ^c,d   Quinn, Thomas C ^c,d   Taljaard, Dirk ^f   Auvert, Bertran ^b,g,h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSERM   (France)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^f Progressus   (South Africa)

^g HÔPITAL AMBROISE PARÉ   (France)

^h LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASSAY; BOOTSTRAPPING; CIRCUMCISION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DATA ANALYSIS; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; OPTICAL DENSITY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; SOUTH AFRICA; SURVIVAL; ADOLESCENT; COMPARATIVE STUDY; EVALUATION; MEDICAL RESEARCH; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

ADOLESCENT; BIOMEDICAL RESEARCH; CIRCUMCISION, MALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77952737404     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-137     Document Type: Article

References (25)

1. Janssen RS, Satten GA, Stramer SL, Rawal BD, O'Brien TR, Weiblen BJ, Hecht FM, Jack N, Cleghorn FR, Kahn JO, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. Jama 1998, 280(1):42-48. 10.1001/jama.280.1.42, 9660362.
2. Parekh BS, Kennedy MS, Dobbs T, Pau CP, Byers R, Green T, Hu DJ, Vanichseni S, Young NL, Choopanya K, et al. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses 2002, 18(4):295-307. 10.1089/088922202753472874, 11860677.
3. Braunstein SL, Wijgert JH, Nash D. HIV incidence in sub-Saharan Africa: a review of available data with implications for surveillance and prevention planning. AIDS Rev 2009, 11(3):140-156.
4. UNAIDS Reference Group on Estimates MaP statement on the use of the BED-assay for the estimation of HIV-1 incidence for surveillance or epidemic monitoring. 2006, UNAIDS, UNAIDS Reference Group on Estimates MaP.
5. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2005, 2(11):e298. 10.1371/journal.pmed.0020298, 1262556,1262556, 16231970.
6. Auvert B, Lissouba P, Cutler E, Zarca K, Puren A, Taljaard D. Association of oncogenic and nononcogenic human papillomavirus with HIV incidence. J Acquir Immune Defic Syndr 2010, 53(1):111-116. 10.1097/QAI.0b013e3181b327e7, 19779357.
7. Silvina Masciotra K, Dobbs T, Candal D, Hanson D, Delaney K, Rudolph D, Man Charurat M, Harrigan R, McDougal S, Owen M. Antibody avidity-based assay for identifying recent HIV-1 infections based on genetic systemsTM1/2 Plus O EIA. CROI 2010: Abstract 937 2010,
8. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998, 17(8):857-872. 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E, 9595616.
9. Marinda ET, Hargrove J, Preiser W, Slabbert H, van Zyl G, Levin J, Moulton LH, Welte A, Humphrey J. Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy. J Acquir Immune Defic Syndr 2010, 53(4):496-499. 10.1097/QAI.0b013e3181b61938, 20306555.
10. Hayashida T, Gatanaga H, Tanuma J, Oka S. Effects of low HIV type 1 load and antiretroviral treatment on IgG-capture BED-enzyme immunoassay. AIDS Res Hum Retroviruses 2008, 24(3):495-498. 10.1089/aid.2007.0150, 18327979.
11. South African National HIV Prevalence, Incidence, Behaviour and Communication Survey, 2008. 2009, HSRC Press, Cape Town, South Africa.
12. McWalter TA, Welte A. Relating recent infection prevalence to incidence with a sub-population of assay non-progressors. J Math Biol 2009, 60(5):687-710. 10.1007/s00285-009-0282-7, 19633851.
13. Hargrove JW. BED estimates of HIV incidence must be adjusted. Aids 2009, 23(15):2061-2062. author reply 2066-2068, 10.1097/QAD.0b013e32832f3d8b, 19755864.
14. Gupta SB, Murphy G, Koenig E, Adon C, Beyrer C, Celentano D, Khawaja S, Sifakis F, Parry JV, Straus W. Comparison of methods to detect recent HIV type 1 infection in cross-sectionally collected specimens from a cohort of female sex workers in the Dominican Republic. AIDS Res Hum Retroviruses 2007, 23(12):1475-1480. 10.1089/aid.2006.0240, 18160004.
15. Barnighausen T, Wallrauch C, Welte A, McWalter TA, Mbizana N, Viljoen J, Graham N, Tanser F, Puren A, Newell ML. HIV incidence in rural South Africa: comparison of estimates from longitudinal surveillance and cross-sectional cBED assay testing. PLoS One 2008, 3(11):e3640. 10.1371/journal.pone.0003640, 2572841, 18982059.
16. Hargrove JW, Humphrey JH, Mutasa K, Parekh BS, McDougal JS, Ntozini R, Chidawanyika H, Moulton LH, Ward B, Nathoo K, et al. Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay. Aids 2008, 22(4):511-518. 10.1097/QAD.0b013e3282f2a960, 18301064.
17. Hallett TB, Ghys P, Barnighausen T, Yan P, Garnett GP. Errors in 'BED'-derived estimates of HIV incidence will vary by place, time and age. PLoS One 2009, 4(5):e5720. 10.1371/journal.pone.0005720, 2684620, 19479050.
18. Sakarovitch C, Rouet F, Murphy G, Minga AK, Alioum A, Dabis F, Costagliola D, Salamon R, Parry JV, Barin F. Do tests devised to detect recent HIV-1 infection provide reliable estimates of incidence in Africa?. J Acquir Immune Defic Syndr 2007, 45(1):115-122. 10.1097/QAI.0b013e318050d277, 17460475.
19. Karita E, Price M, Hunter E, Chomba E, Allen S, Fei L, Kamali A, Sanders EJ, Anzala O, Katende M, et al. Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa. Aids 2007, 21(4):403-408. 10.1097/QAD.0b013e32801481b7, 17301558.
20. Brookmeyer R. Should biomarker estimates of HIV incidence be adjusted?. Aids 2009, 23(4):485-491. 10.1097/QAD.0b013e3283269e28, 19165087.
21. Truong HH, Kellogg T, Louie B, Klausner J, Dilley J, McFarland W. Recent HIV-1 infection detection: comparison of incidence estimates derived by laboratory assays and repeat testing data. J Acquir Immune Defic Syndr 2009, 51(4):502-505. 10.1097/QAI.0b013e3181a25383, 19387356.
22. Wolday D, Meles H, Hailu E, Messele T, Mengistu Y, Fekadu M, Parekh BS, Wuhib T. Temporal trends in the incidence of HIV infection in antenatal clinic attendees in Addis Ababa, Ethiopia, 1995-2003. J Intern Med 2007, 261(2):132-137. 10.1111/j.1365-2796.2006.01740.x, 17241178.
23. Rehle T, Shisana O, Pillay V, Zuma K, Puren A, Parker W. National HIV incidence measures--new insights into the South African epidemic. S Afr Med J 2007, 97(3):194-199.
24. McDougal JS, Parekh BS, Peterson ML, Branson BM, Dobbs T, Ackers M, Gurwith M. Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay. AIDS Res Hum Retroviruses 2006, 22(10):945-952. 10.1089/aid.2006.22.945, 17067263.
25. Mermin J, Musinguzi J, Opio A, Kirungi W, Ekwaru JP, Hladik W, Kaharuza F, Downing R, Bunnell R. Risk factors for recent HIV infection in Uganda. Jama 2008, 300(5):540-549. 10.1001/jama.300.5.540, 18677026.